Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Practice Management Can Improve Efficiency
FRIDAY, June 29, 2018 (HealthDay News) — Providers can take practical steps to improve practice efficiency and increase insurance reimbursement, according to an article published in Dermatology Times.
AMA Calls for Electronic Health Record Training
FRIDAY, June 29, 2018 (HealthDay News) — The American Medical Association (AMA) is calling on medical schools and residency programs to incorporate electronic health record (EHR) training into their curricula.
Prolonged Leisure-Time Sitting Tied to Increased Mortality Risk
FRIDAY, June 29, 2018 (HealthDay News) — Prolonged leisure-time sitting is associated with increased risk of mortality, according to a study published online in the American Journal of Epidemiology.
Abstract/Full Text (subscription or payment may be required)
Penicillin Allergy Linked to MRSA, C. Difficile Risk
THURSDAY, June 28, 2018 (HealthDay News) — There is a correlation for documented penicillin allergy with increased risk of methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile, which is mediated by increased use of β-lactam alternative antibiotics, according to a study published online June 27 in the BMJ.
Health Care Technology Impacts Younger Patient Satisfaction
THURSDAY, June 28, 2018 (HealthDay News) — Health care communication technology is a determinant of patient satisfaction in younger patients, according to a report published by Black Book Market Research LLC.
Most Bleeding Events in Non-CVD Patients Are GI-Related
WEDNESDAY, June 27, 2018 (HealthDay News) — Among a cohort of individuals without cardiovascular disease (CVD) not receiving antiplatelet therapy, most major bleeding events involved gastrointestinal bleeding and 7 percent of bleeding events were fatal, according to a study published online June 26 in the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Sodium Thiosulfate Post-Cisplatin May Lessen Hearing Loss
WEDNESDAY, June 27, 2018 (HealthDay News) — Delayed administration of sodium thiosulfate after cisplatin chemotherapy may prevent treatment-related hearing loss in children with standard-risk hepatoblastoma without affecting survival outcomes, according to a study published online June 21 in the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Authors Explore Overdiagnosis in Cancer Screening
Proportion of Early-Onset Diverticulitis-Related Hospitalizations Increasing 
Children With Autism More Likely to Experience Gastrointestinal Problems 
Lower Rates of Symptom Rebound Seen After H. Pylori Eradication in GERD 
Gut Dysbiosis Linked to Mortality for Solid Organ Transplant Recipients 
Biomarkers Plus Kidney Donor Profile Index Improve Prediction of Concordant Allograft Outcomes 
Lung Transplant Can Prolong Survival in Stage IV NSCLC 
Organ Transplant Survival Rising, but Organ Shortages Persist 
Donation After Circulatory Death Comprises About Half of Deceased Donors 
